Awaiting product image

HrC Genomics Blood test to detect cancer

£1,770.00

  • Results within 24 hours

  • Blood draw included

Next Generation Sequencing (NGS)
HrC Genomics involves processing an individual’s blood sample using Next Generation Sequencing (NGS) technology.
NGS is a technology for determining the sequence of RNA and/or DNA to study genetic variation associated with diseases. In this instance the disease is cancer.
For HrC Genomics, blood samples are processed using two processes i) Whole Exome Sequencing & ii) Whole Transcriptome Sequencing.
Whole Exome Sequencing
In this process, protein making genes in the genome are targeted for DNA sequencing. This allows us to detect whether there are any gene mutations in the DNA that are associated with certain types of diseases. Mutations can cause faulty proteins and disrupt normal body processes.
Whole Transcriptome Sequencing
The same coding regions are targeted as above but use RNA as an input. The main difference here is that the RNA reflects the gene expression of the genome, rather than the sequence of DNA itself. So a difference in RNA expression in certain genes (either up or down regulated) can be associated with certain diseases.
When using the two approaches together, we can detect whether there are any mutations from the DNA, and also whether some mutations might be linked with the changes in respective gene expression. Both are used for biomarker detection but give different outputs.
HrC Technology
The data generated from processing the blood samples using NGS technology now  need to be analysed and interpreted using HrC technology.
HrC is a technology developed by a team of scientists at Epigeneres Biotech in Mumbai. Their technology is based upon the hypothesis that very small embryonic-like stem cells (VSELs), residing in multiple tissues, undergo epigenetic changes and get transformed into Cancer Stem Cells. When this occurs, Cancer Stem Cells from impacted organs in the body get mobilised into circulation in peripheral blood, in increasing numbers. An individual’s risk of cancer presence is dependent upon to what degree that this increase in activity occurs, which can be determined from the data generated from the NGS processing.
HrC Score
The output of the data analysis is the HrC Score which reflects the level of activity being observed. The interpretation of the HrC Score is by way of a proprietary scale developed by Epigeneres, the HrC Scale, which provides an indication of the risk of cancer presence i.e., none, negligible, low, moderate or high.
Please Note
HrC Genomics does not diagnose cancer. It only provides an indication of the risk of cancer presence. Individual’s with suspected cancer symptoms should urgently make an appointment with their GP.
   
HrC Genomics involves processing an individual’s blood sample using Next Generation Sequencing (NGS) technology.
NGS is a technology for determining the sequence of RNA and/or DNA to study genetic variation associated with diseases. In this instance the disease is cancer.
For HrC Genomics, blood samples are processed using two processes i) Whole Exome Sequencing & ii) Whole Transcriptome Sequencing.

To book an appointment:

Call us on
020 8496 0147

Email us at
Contactus@bioma.me

With HrC Genomics, we use the very latest in Next Generation Sequencing (NGS) technology to target genetic biomarkers present in blood, which are known to be key hallmarks of cancer initiation. This means that HrC Genomics can track a patient’s risk of cancer presence from ‘none’ through to ‘high-risk’. It also means that it is possible to obtain an indication of cancer presence in the body prior to symptoms and tumour development.

The output of the test is the HrC Score which indicates whereabouts the patient is on their cancer journey. See www.thehrctest.co.uk /hrc-score for further information.

Conceptually, HrC Genomics can give this information for most cancer, types if not all, as scientists at Epigeneres believe that they have discovered the commonality between all types of cancer in that they all initiate in the same way

We do not claim that HrC can detect cancer, only that HrC can provide an indication of the risk of cancer presence.

For further information about HrC Genomics please visit www.thehrctest.co.uk.